Kuan Chih Chen
Chief Operating Officer at PHARMIGENE, INC.
Profile
Kuan Chih Chen is currently the Chairman at Hung Ya Biotech Co. Ltd.
and the Director & Chief Operating Officer at Pharmigene, Inc. He is also a Director at Chin Lan Biotech Co. Ltd.
Previously, he served as the Director at CytoPharm, Inc. from 2003 to 2013.
He was also a Director at Vita Genomics, Inc. and a Member-Supervisory Board at Merit Biotech, Inc. from 2011 to 2014.
Additionally, he served as a Member-Supervisory Board at Tung Bao Corp.
Mr. Chen received his undergraduate degrees from Aletheia University and Minghsin University of Science & Technology.
Kuan Chih Chen active positions
| Companies | Position | Start |
|---|---|---|
| PHARMIGENE, INC. | Chief Operating Officer | 2019-11-03 |
| Hung Ya Biotech Co. Ltd. | Chairman | 2013-12-02 |
| Chin Lan Biotech Co. Ltd. | Director/Board Member | 2011-09-21 |
Former positions of Kuan Chih Chen
| Companies | Position | End |
|---|---|---|
| MERIT BIOTECH INC | Director/Board Member | 2014-03-09 |
CytoPharm, Inc.
 CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan. | Director/Board Member | 2013-06-20 |
Vita Genomics, Inc.
 Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Director/Board Member | - |
Tung Bao Corp.
 Tung Bao Corp. Chemicals: SpecialtyProcess Industries Tung Bao Corp. engages in the manufacture and sale of chemical products. It operates through three segments: De-aromatics Solvent, Petro-Chemical Acetylene, and E-grade Hydrogen. The Solvents is used in machinery, dry cleaning, carrier, metal processing, anti-rust, and lubricants. The Petro-chemical Acetylene is applied in cutting, welding, and heat treatment. The E-grade hydrogen aims at solar processing, light-emitting diode, semiconductor and petro chemical industries. Tung Bao was founded on September 16, 1987 and is headquartered in New Taipei, Taiwan. | Director/Board Member | - |
Training of Kuan Chih Chen
| Aletheia University | Undergraduate Degree |
| Minghsin University of Science & Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PHARMIGENE, INC. | Health Technology |
| MERIT BIOTECH INC | Health Technology |
| Private companies | 5 |
|---|---|
CytoPharm, Inc.
CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan. | Health Technology |
Vita Genomics, Inc.
Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Health Services |
| Hung Ya Biotech Co. Ltd. | |
| Chin Lan Biotech Co. Ltd. | |
Tung Bao Corp.
Tung Bao Corp. Chemicals: SpecialtyProcess Industries Tung Bao Corp. engages in the manufacture and sale of chemical products. It operates through three segments: De-aromatics Solvent, Petro-Chemical Acetylene, and E-grade Hydrogen. The Solvents is used in machinery, dry cleaning, carrier, metal processing, anti-rust, and lubricants. The Petro-chemical Acetylene is applied in cutting, welding, and heat treatment. The E-grade hydrogen aims at solar processing, light-emitting diode, semiconductor and petro chemical industries. Tung Bao was founded on September 16, 1987 and is headquartered in New Taipei, Taiwan. | Process Industries |
- Stock Market
- Insiders
- Kuan Chih Chen
